New study done in 2019 reveals that SR9009 acts on mobile proliferation independent of Rev-Erb activity, meaning that the consequences of Stenabolic can’t just be attributed towards the Rev-Erb protein. A lot more studies need to be carried out as a way to validate these results.The site is secure. The https:// ensures that you're connecting to y